Literature DB >> 30876698

Delayed Sleep Phase Syndrome: A common sleep disorder in adolescents, with important quality of life repercussions.

Laura Moreno-Galarraga1, Eliot S Katz2.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 30876698      PMCID: PMC6836996          DOI: 10.1016/j.aprim.2019.01.009

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


× No keyword cloud information.
Dear Editor: We have read the article about how sleeping difficulties can be a predictor of worse health-related quality of life. Sleep disorders and delayed sleep phase syndrome (DSPS), are frequently overlooked in adolescents presenting with poor school performance or mood disorders. Primary care doctors should routinely screen for DSPS in adolescents by specifically inquiring about difficulties awakening, late bedtimes, excessive daytime sleepiness, and late weekend wake times. DSPS is one of the most frequently diagnosed sleep disorders in adolescents. It is defined by the International Classification of Sleep Disorders (ICSD) as a circadian rhythm disorder including a delay in the onset of sleep and a great difficulty getting up at conventional hours, (affecting school performance in children, and work, social or family-life in older patients). DSPS is not secondary to pathology or drug intake and it affects patients with normal quantity and quality of sleep when allowed to follow his preferred schedule. Patients with DSPS have a delayed circadian rhythm, which regulates our preferred sleep-wake times, relative to clock time. Consequently, they have difficulty falling asleep at night and waking up in the morning, at the conventional hours, but if allowed to sleep on their preferred schedule, there would be no perceived abnormalities of sleep time or sleep quality. DSPS is different from insomnia in which patients have difficulty initiating sleep at any time and often report poor quality sleep, and therefore should be managed and treated diferently.2, 4 They have a feeling similar to “Jet-Lag,” as if every weekend they are crossing multiple time zones. A person with DSPS, could be quite comfortable going to bed at 3–4 in the morning and getting up at noon. The problem with this schedule is that it interferes with schooling and employment.4, 5 DSPS is common in adolescents, but it can occur at any age. The etiology of this syndrome is complex and multifactorial, including behavioral, psychological and biological factors, and the prevalence between 5 and 10%, is increasing in the last decade.3, 5 Technology use, including screen activity and excessive exposure to artificial light in the evening exacerbates DSPS and caffeine use and napping further dis-regulate the sleep-wake cycle. Recent studies propose as a causal factor a delay in the circadian rhythm due to inadequate melatonin secretion, others propose that the circadian rhythm length is greater than 24 h, or that patients present a diminished neuronal sensitivity to light, but without doubt, an important predisposing factor is when trying to sleep on two different schedules (week and weekends). In these cases, the internal clock will adjust with the latest schedule, the weekend, producing a major problem on week days. Adolescents with DSPS usually have lack of sleep during the week and try to recover it by sleeping until later on weekends, actually worsening the problem.4, 5 The initial treatment is based on adequate sleep hygiene and progressively adjusting the internal clock to social needs, following these basic guidelines: Get up at the same time every day (no differences greater than one hour between week-days and weekend). Be exposed to daylight and have breakfast, just when you get up. Maintain a quiet routine at bedtime, such as reading in dim light. Avoid bright lights and turn off TV, computer and in general any screen one hour before bedtime. Avoid drinks with caffeine after noon (coffee, tea, chocolate, cola or energy drinks). Avoid naps during the day. Adjust the sleep schedule progresively: determining the time at which patient falls asleep naturally and progressively going to bed 10–15 min earlier every night, keeping every day the same get-up time. When these means are not effective, patient should be referred to the sleep specialist to associate chronotherapy with a lightbox or pharmacotherapy with melatonin or other drugs.4, 5, 6 Psychosomatic symptoms, frequent in adolescents, can significantly worsen health-related quality of life (HRQoL) in this population, and sleep is an independent risk factor of worse HRQoL. Primary care doctors must know how to recognize DSPS to prevent school failure, adverse mood disorders and its negative effects on HRQoL.
  5 in total

1.  A randomized controlled trial of cognitive-behavior therapy plus bright light therapy for adolescent delayed sleep phase disorder.

Authors:  Michael Gradisar; Hayley Dohnt; Greg Gardner; Sarah Paine; Karina Starkey; Annemarie Menne; Amy Slater; Helen Wright; Jennifer L Hudson; Edward Weaver; Sophie Trenowden
Journal:  Sleep       Date:  2011-12-01       Impact factor: 5.849

Review 2.  Delayed sleep-wake phase disorder.

Authors:  Alexander D Nesbitt
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

Review 3.  The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders.

Authors:  Seithikurippu R Pandi-Perumal; Ilya Trakht; D Warren Spence; Venkataramanujan Srinivasan; Yaron Dagan; Daniel P Cardinali
Journal:  Nat Clin Pract Neurol       Date:  2008-07-15

Review 4.  Delayed sleep phase disorder in youth.

Authors:  Michael Gradisar; Stephanie J Crowley
Journal:  Curr Opin Psychiatry       Date:  2013-11       Impact factor: 4.741

5.  [Psychosomatic symptoms as an expression of the deterioration of the health-related quality of life in adolescents].

Authors:  Rosa M Fuentes Chacón; M José Simón Saiz; Margarita Garrido Abejar; M Dolores Serrano Parra; M Elisa Larrañaga Rubio; Santiago Yubero Jiménez
Journal:  Aten Primaria       Date:  2017-12-06       Impact factor: 1.137

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.